MedPath

NEXT CHOICE

Levonorgestrel Tablets, 0.75 mg

Approved
Approval ID

eb0e7e5e-36c4-4478-9200-fdb9149979f3

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 1, 2009

Manufacturers
FDA

Rebel Distributors Corp.

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Levonorgestrel

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-443
Application NumberANDA078666
Product Classification
M
Marketing Category
C73584
G
Generic Name
Levonorgestrel
Product Specifications
Route of AdministrationORAL
Effective DateJuly 1, 2009
FDA Product Classification

INGREDIENTS (7)

LEVONORGESTRELActive
Quantity: 0.75 mg in 1 1
Code: 5W7SIA7YZW
Classification: ACTIB
COLLOIDAL SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NEXT CHOICE - FDA Drug Approval Details